2017 tables: Institutions - corporate

The 2017 tables are based on Nature Index data from 1 January 2016 to 31 December 2016.

Table criteria

# Institution Share 2015 Share 2016 Count 2016 Change in Adjusted Share 2015-2016*
1 IBM Corporation, United States of America (USA) 62.14 42.90 105 -29.2%
2 Merck & Co., Inc., United States of America (USA) 26.32 29.74 71 15.9%
3 Pfizer Inc., United States of America (USA) 20.58 28.05 61 39.8%
4 Amgen Inc., United States of America (USA) 17.02 20.35 55 22.6%
5 Alphabet Inc., United States of America (USA) 3.00 11.58 30 296.0%
6 Microsoft Corporation, United States of America (USA) 5.66 11.06 50 100.4%
7 Eli Lilly and Company, United States of America (USA) 10.98 9.79 51 -8.5%
8 Thermo Fisher Scientific Inc., United States of America (USA) 6.64 8.49 45 31.1%
9 Dow Inc., United States of America (USA) 8.52 8.31 28 0.0%
10 Johnson & Johnson, United States of America (USA) 7.12 7.77 24 12.0%
11 Bristol-Myers Squibb (BMS), United States of America (USA) 14.05 7.53 29 -45.0%
12 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 4.27 7.32 27 75.6%
13 Science Systems and Applications, Inc. (SSAI), United States of America (USA) 5.70 6.84 37 23.0%
14 HP Inc., United States of America (USA) 0.66 6.66 10 936.3%
15 E. I. du Pont de Nemours and Company (DuPont), United States of America (USA) 3.89 6.23 15 64.4%
16 HRL Laboratories LLC, United States of America (USA) 4.49 5.75 9 31.6%
17 Leidos Holdings, Inc., United States of America (USA) 7.01 5.36 64 -21.5%
18 Western Digital Corporation, United States of America (USA) 2.08 5.23 13 157.9%
19 Bruker Corporation, United States of America (USA) 7.32 4.88 36 -31.6%
20 Regeneron Pharmaceuticals, Inc., United States of America (USA) 4.43 4.57 10 6.0%
21 Biogen Inc., United States of America (USA) 1.36 4.54 17 242.5%
22 Ionis Pharmaceuticals, Inc., United States of America (USA) 4.92 4.24 20 -11.5%
23 Constellation Pharmaceuticals, Inc., United States of America (USA) 4.00 6 N/A
24 Atmospheric and Environmental Research, Inc. (AER), United States of America (USA) 4.80 3.83 8 -18.0%
25 Chevron Corporation, United States of America (USA) 2.85 3.29 21 18.7%
26 Seattle Genetics, Inc., United States of America (USA) 2.00 3.03 4 55.3%
27 New England Biolabs, Inc. (NEB), United States of America (USA) 5.63 2.90 7 -47.2%
28 Illumina, Inc., United States of America (USA) 3.87 2.71 21 -28.2%
29 Agilent Technologies, Inc., United States of America (USA) 3.76 2.51 11 -31.4%
30 Gilead Sciences, Inc., United States of America (USA) 3.13 2.50 11 -18.0%
31 Intel Corporation, United States of America (USA) 2.71 2.43 25 -8.2%
32 Applied Materials, Inc., United States of America (USA) 0.93 2.25 27 149.3%
33 Momenta Pharmaceuticals, Inc., United States of America (USA) 1.09 2.24 3 111.8%
34 AbbVie Inc., United States of America (USA) 2.89 2.23 8 -20.8%
35 GATS Inc., United States of America (USA) 2.87 2.22 8 -20.7%
36 Waters Corporation, United States of America (USA) 4.44 2.18 9 -49.7%
37 Ford Motor Company, United States of America (USA) 1.22 2.17 4 82.2%
38 Soraa Inc., United States of America (USA) 1.00 2.00 2 105.1%
38 Q2 Solutions, United States of America (USA) 2.00 2 N/A
39 Euclid TechLabs LLC, United States of America (USA) 0.12 1.99 6 1,631.8%
40 Xerox Corporation, United States of America (USA) 5.39 1.93 17 -63.3%
41 Aerodyne Research, Inc. (ARI), United States of America (USA) 5.80 1.91 20 -66.3%
42 23andMe, Inc., United States of America (USA) 1.78 1.82 14 4.8%
43 GeneDx Inc., United States of America (USA) 0.70 1.80 16 165.1%
44 Pacific Biosciences of California, Inc., United States of America (USA) 1.44 1.80 11 27.9%
45 Northrop Grumman Corporation, United States of America (USA) 0.35 1.75 17 415.0%
46 Hysitron, Inc., United States of America (USA) 0.88 1.74 10 102.8%
47 NorthWest Research Associates, Inc. (NWRA), United States of America (USA) 3.77 1.74 18 -52.8%
48 Schlumberger Limited, United States of America (USA) 1.54 1.69 10 12.4%
49 Jacobs, United States of America (USA) 0.41 1.65 11 311.0%
50 Lockheed Martin Corporation, United States of America (USA) 4.26 1.60 16 -61.4%
51 Danaher Corporation, United States of America (USA) 3.88 1.59 9 -57.8%
52 Colgate-Palmolive Company, United States of America (USA) 1.49 3 N/A
53 Peloton Therapeutics, Inc., United States of America (USA) 1.48 3 N/A
54 Polyera Corporation, United States of America (USA) 1.16 1.46 9 28.9%
55 Promega Corporation, United States of America (USA) 2.82 1.43 5 -48.0%
56 Synthetic Genomics, Inc. (SGI), United States of America (USA) 1.40 3 N/A
57 ConocoPhillips Company, United States of America (USA) 1.11 1.37 4 26.1%
58 Stinger Ghaffarian Technologies (SGT), United States of America (USA) 0.51 1.34 5 171.1%
59 Dynavax Technologies Corp., United States of America (USA) 0.03 1.33 3 3,977.2%
60 Dow AgroSciences, United States of America (USA) 2.33 1.29 6 -43.4%
61 Integral Molecular, Inc., United States of America (USA) 0.54 1.29 4 143.0%
62 Kolltan Pharmaceuticals, Inc., United States of America (USA) 0.56 1.25 2 130.8%
62 Gelest, Inc., United States of America (USA) 1.25 3 N/A
63 Vertex Pharmaceuticals Incorporated, United States of America (USA) 2.33 1.22 6 -46.5%
64 Merrimack Pharmaceuticals, Inc., United States of America (USA) 1.21 2 N/A
65 General Electric Company (GE), United States of America (USA) 5.66 1.21 8 -78.0%
66 General Atomics, United States of America (USA) 3.20 1.20 12 -61.6%
67 NuMat Technologies, United States of America (USA) 0.90 1.18 2 34.2%
68 Oncomed Pharmaceuticals, Inc., United States of America (USA) 1.17 2 N/A
69 General Motors (GM), United States of America (USA) 1.81 1.14 5 -35.5%
70 10x Genomics, United States of America (USA) 1.12 3 N/A
71 AECOM, United States of America (USA) 0.66 1.12 4 73.3%
72 I.M. Systems Group, Inc. (IMSG), United States of America (USA) 0.56 1.05 27 91.0%
73 Foundation Medicine, Inc., United States of America (USA) 1.04 6 N/A
74 Computational Physics, Inc., United States of America (USA) 0.66 1.03 3 60.4%
75 Sangamo Therapeutics Inc., United States of America (USA) 2.59 1.03 2 -59.3%
76 BioNano Genomics, United States of America (USA) 0.44 1.01 4 132.9%
77 Exponent, Inc., United States of America (USA) 1.00 2 N/A
78 Biodesy, Inc., United States of America (USA) 0.20 1.00 1 412.9%
78 Selecta Biosciences, Inc., United States of America (USA) 0.63 1.00 1 64.1%
78 NUSOD Institute LLC, United States of America (USA) 1.33 1.00 1 -23.1%
78 Alexion Pharmaceuticals, Inc., United States of America (USA) 3.14 1.00 1 -67.3%
78 Disney Research, United States of America (USA) 1.00 1 N/A
78 Amyris, Inc., United States of America (USA) 1.00 1 N/A
78 Atom NanoElectronics Inc., United States of America (USA) 1.00 1 N/A
78 BioMedomics, Inc., United States of America (USA) 1.00 1 N/A
78 Philip Morris International Inc. (PMI), United States of America (USA) 1.00 1 N/A
78 LGS Innovations, United States of America (USA) 1.00 1 N/A
78 Adesto Technologies Corporation, Inc., United States of America (USA) 1.00 1 N/A
79 Ametek, Inc., United States of America (USA) 0.99 4 N/A
80 Human Longevity, Inc., United States of America (USA) 0.80 0.99 2 26.1%
81 Thorlabs, Inc., United States of America (USA) 0.06 0.98 3 1,506.9%
82 PsychoGenics Inc., United States of America (USA) 0.96 3 N/A
83 Procter & Gamble (P&G), United States of America (USA) 1.39 0.96 3 -29.2%
84 Nion Company, United States of America (USA) 0.94 3 N/A
85 Arvinas Inc., United States of America (USA) 0.10 0.93 1 820.7%
86 Aptitude Medical Systems Inc., United States of America (USA) 0.92 2 N/A
86 Spin Transfer Technologies, United States of America (USA) 0.11 0.92 2 746.2%
87 ActivX Biosciences, Inc., United States of America (USA) 0.90 1 N/A
88 Altor BioScience Corporation, United States of America (USA) 0.86 2 N/A
89 Seagate Technology LLC, United States of America (USA) 0.69 0.85 3 25.9%
90 Corning Incorporated, United States of America (USA) 1.21 0.84 5 -28.6%
91 Crown Bioscience Inc., United States of America (USA) 0.83 1 N/A
92 Novogy, Inc., United States of America (USA) 0.82 1 N/A
93 VUV Analytics, Inc., United States of America (USA) 0.81 3 N/A
94 Dovetail Genomics LLC, United States of America (USA) 0.80 2 N/A
95 Global Aquatic Research LLC (GAR), United States of America (USA) 0.22 0.79 4 272.4%
96 RJ Lee Group, Inc., United States of America (USA) 0.78 2 N/A
97 Brown and Caldwell, Inc. (BC), United States of America (USA) 0.17 0.76 4 367.9%
98 Leco Corporation, United States of America (USA) 0.13 0.76 2 521.6%
99 Molecular Vista, United States of America (USA) 0.11 0.75 3 592.4%
99 Diagnostics For All (DFA), United States of America (USA) 0.67 0.75 1 15.4%
99 WeatherTiger, LLC, United States of America (USA) 0.75 1 N/A
99 Voss Scientific, LLC - Research & Development, United States of America (USA) 0.75 1 N/A
99 Bioremediation Consulting Inc., United States of America (USA) 0.75 1 N/A
99 Array Information Technology, United States of America (USA) 0.75 2 N/A
100 PTC Therapeutics, United States of America (USA) 0.10 0.75 3 667.1%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.